CRO concept stocks are showing strong gains in early trading on the Hong Kong market, with several key players posting significant advances.
Asymchem Laboratories Tianjin Co Ltd (06821) jumped 8.87% to HK$146.10, while Tigermed (03347) climbed 7.01% to HK$44.30 as of the latest update. Other notable performers include Pharmaron Beijing Co Ltd (03759), which advanced 6.54% to HK$29.34, and WuXi Biologics (02269), which gained 3.62% to HK$48.70.
The upward momentum in the sector reflects renewed investor interest in contract research organizations, with trading volumes picking up across the board as the session progresses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments